| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | insulin glargine (Toujeo®) |
| Formulation | 300 U/ml solution for injection |
| Reference number | 2321 |
| Indication | Treatment of diabetes mellitus in adults |
| Company | Sanofi-Aventis Ltd |
| BNF chapter | Endocrine system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 17/04/2015 |